US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 0.870
- -0.040-4.42%
Close May 17 16:00 ET
- 0.895
- +0.025+2.91%
Pre 08:57 ET
11.65MMarket Cap-171P/E (TTM)
0.913High0.834Low59.72KVolume0.910Open0.910Pre Close51.90KTurnover0.55%Turnover RatioLossP/E (Static)13.39MShares14.55052wk High-2.96P/B9.39MFloat Cap0.51452wk Low--Dividend TTM10.79MShs Float14.550Historical High--Div YieldTTM8.68%Amplitude0.514Historical Low0.869Avg Price1Lot Size
Psyence Biomedical Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|
| Operating Cash Flow (Indirect Method) | ||
| Cash flow from continuing operating activities | -11.11%-1.94M | -1.74M |
| Net income from continuing operations | -82.70%-4.24M | ---2.32M |
| Change In working capital | 1,140.05%2.01M | --161.98K |
| -Change in receivables | -222.31%-152.78K | --124.91K |
| -Change in prepaid assets | -61,066.88%-97.55K | --160 |
| -Change in payables and accrued expense | 6,020.20%2.26M | --36.91K |
| Cash from discontinued investing activities | ||
| Operating cash flow | -11.11%-1.94M | ---1.74M |
| Investing cash flow | ||
| Cash flow from continuing investing activities | 0 | -40K |
| Net other investing changes | ---- | ---40K |
| Cash from discontinued investing activities | ||
| Investing cash flow | --0 | ---40K |
| Financing cash flow | ||
| Cash flow from continuing financing activities | 176.37%1.55M | -2.03M |
| Net other financing activities | 176.37%1.55M | ---2.03M |
| Cash from discontinued financing activities | ||
| Financing cash flow | 176.37%1.55M | ---2.03M |
| Net cash flow | ||
| Beginning cash position | -63.52%2.19M | --6.01M |
| Current changes in cash | 89.90%-385.33K | ---3.82M |
| End cash Position | -17.59%1.81M | --2.19M |
| Free cash flow | -11.11%-1.94M | ---1.74M |
| Currency Unit | CAD | CAD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg